Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™
InVera Medical™ (formerly known as Venari Medical) are delighted to announce the publication of its pre-clinical feasibility study of the InVera™ minimally invasive, exclusively mechanical venous ablation device in Phlebology, an official journal of several international venous societies. The study... Read More →
MindMaze to advance digital neurotherapeutics with $105-million raise
MindMaze announced Thursday that it secured a $105-million financing round to accelerate its global growth plans, support ongoing R&D and consolidate the clinical development pipeline of its digital therapeutic solutions for neurological diseases. “This funding allows us to ramp up commercial activity... Read More →
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System
FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States Epitel introduces REMI, a wearable, wireless EEG monitoring platform for seizure detection. Epitel’s first FDA-cleared product can be... Read More →
Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix™ Product Platform
Oxford, UK – 9th February 2022 – Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.3m (£3.2m) to close its $12.5m (£9.2m) Series... Read More →
Day Zero Diagnostics Announces Completion of $21M Financing
BOSTON – February 9, 2022 – Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, announced the completion of a $21M venture equity financing. The round... Read More →
Feb 8, 2022 Entrepreneurship Impact Spotlights News and Events From Plastic Surgeon-in-Training to Inventor: How a Family Tragedy Led One Latina to Improve Lung Disease Diagnosis for the World
Maria Artunduaga is the CEO and founder of Samay, a successful startup aimed at providing low-cost, at-home diagnostics for dangerous respiratory conditions. At age 34, Maria Artunduaga took a leap of faith. Ambitious and focused, she was studying plastic surgery... Read More →
Koya Medical secures US$26 million in Series B funding to advance portfolio of active compression therapies for lymphoedema and venous disorders
Koya Medical has announced the close of a US$26 million Series B financing. The round was led by 3×5 Partners, along with new investors including Asahi Kasei Ventures, Cadence Healthcare Ventures, and existing investors Arboretum Ventures and Scientific Health Development,... Read More →
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
CroíValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a Series A round to fund a Feasibility clinical study with its DUO Coaptation Valve system. This novel approach to treating tricuspid regurgitation combines... Read More →
Applaud Medical wins FDA breakthrough device designation for urinary stone device
Applaud Medical Inc. has secured breakthrough device designation from the FDA for its acoustic enhancer technology to be used in conjunction with ureteroscopy with laser lithotripsy (URS-LL) for the fragmentation of calcium-based urinary stones. The San Francisco-based company is currently... Read More →
Vynca Secures $30 Million in Funding to Expand Integrated Palliative Care Platform
Vynca, a leading technology-enabled provider of holistic care for those with serious illnesses, raised $30 million in growth capital. The investment was led by Questa Capital with participation from existing investors including Generator Ventures, First Trust Capital Partners, 4100 Group... Read More →